Last €13.72 EUR
Change Today +0.203 / 1.50%
Volume 0.0
FR2 On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 11:53 AM 10/21/14 All times are local (Market data is delayed by at least 15 minutes).

elizabeth arden inc (FR2) Snapshot

Open
€13.36
Previous Close
€13.51
Day High
€13.72
Day Low
€13.21
52 Week High
11/28/13 - €28.96
52 Week Low
08/20/14 - €11.09
Market Cap
408.9M
Average Volume 10 Days
19.6
EPS TTM
--
Shares Outstanding
29.8M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ELIZABETH ARDEN INC (FR2)

elizabeth arden inc (FR2) Related Businessweek News

View More BusinessWeek News

elizabeth arden inc (FR2) Details

Elizabeth Arden, Inc., a beauty products company, is engaged in the manufacture, distribution, marketing, and sale of fragrances, skin care, and cosmetic products worldwide. The company offers various fragrance products for men and women, including perfume, colognes, eau de toilettes, eau de parfums, and gift sets, as well as bath and body products, such as soaps, deodorants, body lotions, gels, creams, body and hair mists, and dusting powders. It also provides skin care products comprising serums, moisturizers, and cleansers; and cosmetics consisting of foundations, lipsticks, mascaras, eye shadows, and powders. The company’s brand portfolio includes Elizabeth Arden branded lipstick, foundation, and other color cosmetics products, such as Visible Difference, Ceramide, Prevage, and Eight Hour Cream; Elizabeth Arden fragrances comprising Red Door, Elizabeth Arden 5th Avenue, Elizabeth Arden Green Tea, and UNTOLD; and celebrity fragrance brands of Britney Spears, Elizabeth Taylor, Mariah Carey, Taylor Swift, Justin Bieber, Nicki Minaj, and Jennifer Aniston. Its lifestyle fragrance brands consists of Curve, Giorgio Beverly Hills, PS Fine Cologne, and White Shoulders; and designer fragrance brands comprising Juicy Couture, Alfred Sung, BCBGMAXAZRIA, Ed Hardy, Geoffrey Beene, Halston, John Varvatos, Lucky, Rocawear, and Wildfox Couture. The company sells its products primarily to department and specialty stores, mass retailers, perfumeries, boutiques, distributors, and travel retail outlets, as well as to independent fragrance, cosmetic, gift, and other stores. It also markets and sells its products through its e-commerce site at elizabetharden.com. The company was founded in 1960 and is headquartered in Miramar, Florida.

2,195 Employees
Last Reported Date: 08/25/14
Founded in 1960

elizabeth arden inc (FR2) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $898.3K
Executive Vice President and General Manager ...
Total Annual Compensation: $523.8K
Executive Vice President and General Manager ...
Total Annual Compensation: $495.8K
Compensation as of Fiscal Year 2013.

elizabeth arden inc (FR2) Key Developments

Elizabeth Arden, Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended June 30, 2014; Provides Earnings Guidance for the Fiscal 2015

Elizabeth Arden, Inc. announced unaudited consolidated earnings results for the fourth quarter and year ended June 30, 2014. For the quarter, the company reported net sales were $191.72 million against $267.58 million a year ago. Loss before income taxes was $101.85 million against $10.87 million a year ago. Net loss attributable to the company was $155.93 million against $5.01 million a year ago. Diluted loss per share was $5.24 against $0.17 a year ago. LBITDA was $81.16 million against profit of $7.46 million a year ago. Adjusted to exclude non-recurring costs, net of taxes, net sales were $201.18 million against $267.58 million a year ago. Net loss attributable to the company was $30.83 million against profit of $3.12 million a year ago. Diluted loss per share was $1.04 against profit of $0.10 a year ago. LBITDA was $24.75 million against profit of $21.84 million a year ago. For the full year, the company reported net sales were $1,164.3 million against $1,344.52 million a year ago. Loss before income taxes was $90.36 million against profit of $47.65 million a year ago. Net loss attributable to the company was $145.73 million against profit of $40.7 million a year ago. Diluted loss per share was $4.90 against profit of $1.33 a year ago. LBITDA was $12.4 million against profit of $117.93 million a year ago. Adjusted to exclude non-recurring costs, net of taxes, net sales were $1,173.77 million against $1,344.52 million a year ago. Net loss attributable to the company was $16.28 million against profit of $65.33 million a year ago. Diluted loss per share was $0.55 against profit of $2.14 a year ago. EBITDA was $47.44 million against $156.71 million a year ago. Net cash used in operating activities was $38.045 million against $62.091 million a year ago. Capital expenditures for the year totaled $46.6 million. For the fiscal 2015, the company will be focused on stabilizing the business and will be the first year of a multi-year plan to rebuild profitability. The company expects a modest improvement in adjusted earnings for fiscal 2015 over the prior year with continued improvement in fiscal 2016. Specifically, for fiscal 2015, the company currently expects the following: The first quarter of fiscal 2015 will continue to be challenged by the same factors that affected recent quarters. Net sales headwinds to continue for the first half of fiscal 2015, resulting primarily from a lower level of product innovation as compared to the first half of the prior fiscal year. Net sales increases in the second half of the fiscal year versus the prior year period as the year-over-year product launch comparisons moderate and the company begins to realize the impact of improved pricing. Gross margin expansion due to improved pricing, better mix, lower discounts and realization of reduced supply chain and product costs. Improved EBITDA margins from gross margin expansion and lower selling, general and administrative expenses. Stronger cash flow from operations as a result of higher earnings and lower investment in inventory. The company currently expects capital expenditures for fiscal 2015 to total approximately $32 million to $35 million.

Elizabeth Arden, Inc. to Report Q4, 2014 Results on Aug 19, 2014

Elizabeth Arden, Inc. announced that they will report Q4, 2014 results at 8:00 PM, GMT Standard Time on Aug 19, 2014

Elizabeth Arden, Inc., Q4 2014 Earnings Call, Aug 19, 2014

Elizabeth Arden, Inc., Q4 2014 Earnings Call, Aug 19, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FR2:GR €13.72 EUR +0.203

FR2 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Blyth Inc $7.80 USD -0.02
Helen of Troy Ltd $60.02 USD +1.17
Lifetime Brands Inc $16.79 USD +0.53
USANA Health Sciences Inc $85.25 USD +2.54
Zep Inc $14.88 USD +0.03
View Industry Companies
 

Industry Analysis

FR2

Industry Average

Valuation FR2 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.4x
Price/Book 1.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ELIZABETH ARDEN INC, please visit www.elizabetharden.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.